Oncology Nursing Society (ONS), in partnership with Oncology Nursing Certification Corporation (ONCC) · Current official course outline, page updated 2025-12-31; reviewed 2026-10-11. The workbook label maps to this assessment-based certificate course and its post-test. No separate numbered examination blueprint or effective date is stated.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• ONS/ONCC® Chemotherapy Immunotherapy Certificate™
• The Story of Credentialing
• Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards
• Chemical Hazards Risk Factors
• NCI Drug Dictionary: Cyclophosphamide
• NCI Drug Dictionary: Fluorouracil
• NCI Drug Dictionary: Doxorubicin Hydrochloride
• NCI Drug Dictionary: Paclitaxel
• Targeted Therapy to Treat Cancer
• Hormone Therapy to Treat Cancer
• Immune Checkpoint Inhibitors
• Vincristine Sulfate Injection: Prescribing Information
• Doxorubicin Hydrochloride Injection: Prescribing Information
• Cyclophosphamide for Injection: Prescribing Information
• Paclitaxel Injection, Solution, Concentrate: Prescribing Information
• KEYTRUDA (Pembrolizumab): Prescribing Information and Medication Guide
• Extravasation Management
• Safety labeling update for capecitabine and fluorouracil (5-FU) on risks associated with dihydropyrimidine dehydrogenase (DPD) deficiency | FDA
• These highlights do not include all the information needed to use VISTOGARD safely and effectively. See full prescribing information for VISTOGARD. VISTOGARD ®(uridine triacetate) oral granules Initial U.S. Approval: 2015
• DailyMed - HERCEPTIN- trastuzumab injection, powder, lyophilized, for solution
• DailyMed